300 related articles for article (PubMed ID: 9386228)
1. Pharmaceutical treatment of obesity.
Blackburn GL; Miller D; Chan S
Nurs Clin North Am; 1997 Dec; 32(4):831-48. PubMed ID: 9386228
[TBL] [Abstract][Full Text] [Related]
2. The pharmacologic management of obesity.
Cerda JJ
J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
[No Abstract] [Full Text] [Related]
3. Orlistat for obesity.
Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
[No Abstract] [Full Text] [Related]
4. Fixed-dose combination of phentermine-topiramate for the treatment of obesity.
Halpern B; Faria AM; Halpern A
Expert Rev Clin Pharmacol; 2013 May; 6(3):235-41. PubMed ID: 23656337
[TBL] [Abstract][Full Text] [Related]
5. Two anti-obesity hopefuls and their safety.
Bello NT; Campbell SC
Expert Opin Drug Saf; 2012 Sep; 11(5):681-3. PubMed ID: 22788876
[No Abstract] [Full Text] [Related]
6. How physician obesity specialists use drugs to treat obesity.
Hendricks EJ; Rothman RB; Greenway FL
Obesity (Silver Spring); 2009 Sep; 17(9):1730-5. PubMed ID: 19300434
[TBL] [Abstract][Full Text] [Related]
7. New drug targets for the treatment of obesity.
Powell AG; Apovian CM; Aronne LJ
Clin Pharmacol Ther; 2011 Jul; 90(1):40-51. PubMed ID: 21654742
[TBL] [Abstract][Full Text] [Related]
8. Combination phentermine/topiramate for obesity treatment in primary care: a review.
Xiong GL; Gadde KM
Postgrad Med; 2014 Mar; 126(2):110-6. PubMed ID: 24685974
[TBL] [Abstract][Full Text] [Related]
9. The FDA's assessment of two drugs for chronic weight management.
Colman E; Golden J; Roberts M; Egan A; Weaver J; Rosebraugh C
N Engl J Med; 2012 Oct; 367(17):1577-9. PubMed ID: 23050510
[No Abstract] [Full Text] [Related]
10. Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity.
Rothman RB
J Clin Psychiatry; 1996 Feb; 57(2):92-3. PubMed ID: 8591979
[No Abstract] [Full Text] [Related]
11. 2 new drugs for weight loss.
Med Lett Drugs Ther; 2012 Sep; 54(1398):69-71. PubMed ID: 22992487
[No Abstract] [Full Text] [Related]
12. Bitter pills, bad medicine.
Golden F
Time; 2001 Jun; 157(22):76. PubMed ID: 11432381
[No Abstract] [Full Text] [Related]
13. Novel pharmacotherapies for obesity poised to enter market.
Jones D
Nat Rev Drug Discov; 2009 Nov; 8(11):833-4. PubMed ID: 19876031
[No Abstract] [Full Text] [Related]
14. [The principle of precaution and the drug treatment of obese subjects].
C-Soriguer FJ; Tinahones FJ
Med Clin (Barc); 1999 Apr; 112(13):503-7. PubMed ID: 10353118
[No Abstract] [Full Text] [Related]
15. Pharmacological therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
[TBL] [Abstract][Full Text] [Related]
16. Appetite suppressants for obesity.
Budenholzer B
J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
[No Abstract] [Full Text] [Related]
17. Are we treating health or physical appearance when we prescribe drugs for obesity?
Reidenberg MM
Clin Pharmacol Ther; 2000 Mar; 67(3):193-5. PubMed ID: 10741620
[No Abstract] [Full Text] [Related]
18. Cetilistat, a new lipase inhibitor for the treatment of obesity.
Padwal R
Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the discovery and development of new agents for the treatment of obesity.
Staten MA
Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527
[TBL] [Abstract][Full Text] [Related]
20. New agent for obesity management.
Clemenson ND
J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
